Izotropic Corporation (CSE:IZO)

Market Cap	30.36M
Revenue (ttm)	n/a
Net Income (ttm)	-2.31M
Shares Out	66.73M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,345
Average Volume	45,977
Open	0.4700
Previous Close	0.4700
Day's Range	0.4550 - 0.4700
52-Week Range	0.0350 - 0.4850
Beta	1.22
RSI	63.56
Earnings Date	Dec 30, 2025

About Izotropic

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360‐degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2016
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: IZO